FRIEL ROBERT F
SEC CIK 1224110 · EDGAR
Most active insiders at XYL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Toussaint Claudia S | EVP, CPSO | — | $1.59M |
| 2 | McShane Geri-Michelle | SVP, CAO | — | $501.4K |
| 3 | Harker Victoria D | Dir | — | $251.8K |
| 4 | Peribere Jerome A | Dir | $141.1K | — |
| 5 | van der Berg Andrea Michele | EVP, CFO | — | — |
| 6 | Johnston Joseph Patrick | EVP, Pres, AW | — | — |
| 7 | Emmerich Meredith | EVP, Pres, AW | — | — |
| 8 | Cho Albert | EVP, Strategy | — | — |
| 9 | McGann Michael J. | EVP, Pres, MCS | — | — |
| 10 | ELLIS EARL RAY | Dir | — | — |
| 20 | FRIEL ROBERT F | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 16:16 | 2026-05-14 | XYL | Xylem Inc. | FRIEL ROBERT F | Dir | A - Grant | $116.88 | +2,481 | 38.7K | +7% | +$290.0K | |
| 2026-05-06 17:23 | 2026-05-04 | WST | West Pharmaceutical Services | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +791 | 5,513 | +17% | $0 | |
| 2025-05-14 | 2025-05-13 | XYL | Xylem Inc. | FRIEL ROBERT F | Dir | A - Grant | $126.93 | +1,851 | 36.0K | +5% | +$234.9K | |
| 2025-05-08 | 2025-05-06 | WST | West Pharmaceutical Services | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +1,071 | 4,682 | +30% | $0 | |
| 2024-05-20 | 2024-05-16 | XYL | Xylem Inc. | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +1,647 | 33.9K | +5% | $0 | |
| 2024-04-25 | 2024-04-23 | WST | West Pharmaceutical Services | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +564 | 3,611 | +19% | $0 | |
| 2023-05-22 | 2023-05-18 | XYL | Xylem Inc. | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +2,250 | 32.0K | +8% | $0 | |
| 2023-04-27 | 2023-04-25 | WST | West Pharmaceutical Services | FRIEL ROBERT F | Dir | A - Grant | — | +616 | 3,047 | +25% | — | |
| 2022-05-26 | 2022-05-24 | WST | West Pharmaceutical Services | FRIEL ROBERT F | Dir | A - Grant | — | +632 | 2,431 | +35% | — | |
| 2022-05-16 | 2022-05-12 | XYL | Xylem Inc. | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +2,627 | 29.5K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations